Search research articles
Contact Us
Filters
Showing results (1-10 of 176) with videos related to
Page
of 18
Sort By:
Digestive Diseases (Basel, Switzerland)
|
September 14, 2013
Cross-sectional imaging modalities in Crohn's disease
Mariangela Allocca, Gionata Fiorino, Silvio Danese
Current Drug Targets
|
September 13, 2014
Iron deficiency: the hidden miscreant in inflammatory bowel disease
Mariangela Allocca, Gionata Fiorino, Silvio Danese
United European Gastroenterology Journal
|
March 28, 2020
Impact of therapies on bowel damage in Crohn's disease
Gionata Fiorino, Cristiana Bonifacio, Mariangela Allocca, et al.
Immunotherapy
|
February 26, 2015
Progress with anti-tumor necrosis factor therapeutics for the treatment of inflammatory bowel disease
Carlos Fernandes, Mariangela Allocca, Silvio Danese, et al.
Current Opinion in Pharmacology
|
December 22, 2015
Integrins and adhesion molecules as targets to treat inflammatory bowel disease
Ivana Bravatà, Mariangela Allocca, Gionata Fiorino, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 9, 2019
Use of Cross-Sectional Imaging for Tight Monitoring of Inflammatory Bowel Diseases
Mariangela Allocca, Silvio Danese, Valérie Laurent, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
August 23, 2011
Oxysterols in bile acid metabolism
Andrea Crosignani, Massimo Zuin, Mariangela Allocca, et al.
Gastroenterology
|
June 8, 2025
Role of Noninvasive Imaging in the Diagnosis and Management of Patients With Suspected and Established Inflammatory Bowel Disease
Torsten Kucharzik, Mariangela Allocca, Joana Torres, et al.
Expert Review of Gastroenterology & Hepatology
|
January 15, 2016
Emerging therapeutic targets and strategies in Crohn's disease
Federica Furfaro, Gionata Fiorino, Mariangela Allocca, et al.
Journal of Gastroenterology
|
July 9, 2024
Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment-insights from Phase II and III trials
Sara Massironi, Federica Furfaro, Sarah Bencardino, et al.
Page
of 18
Search research articles
Search
Showing results (1-10 of 176) with videos related to
Sort By:
Page
of 18
Digestive Diseases (Basel, Switzerland)
|
September 14, 2013
Cross-sectional imaging modalities in Crohn's disease
Mariangela Allocca, Gionata Fiorino, Silvio Danese
Current Drug Targets
|
September 13, 2014
Iron deficiency: the hidden miscreant in inflammatory bowel disease
Mariangela Allocca, Gionata Fiorino, Silvio Danese
United European Gastroenterology Journal
|
March 28, 2020
Impact of therapies on bowel damage in Crohn's disease
Gionata Fiorino, Cristiana Bonifacio, Mariangela Allocca, et al.
Immunotherapy
|
February 26, 2015
Progress with anti-tumor necrosis factor therapeutics for the treatment of inflammatory bowel disease
Carlos Fernandes, Mariangela Allocca, Silvio Danese, et al.
Current Opinion in Pharmacology
|
December 22, 2015
Integrins and adhesion molecules as targets to treat inflammatory bowel disease
Ivana Bravatà, Mariangela Allocca, Gionata Fiorino, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 9, 2019
Use of Cross-Sectional Imaging for Tight Monitoring of Inflammatory Bowel Diseases
Mariangela Allocca, Silvio Danese, Valérie Laurent, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
August 23, 2011
Oxysterols in bile acid metabolism
Andrea Crosignani, Massimo Zuin, Mariangela Allocca, et al.
Gastroenterology
|
June 8, 2025
Role of Noninvasive Imaging in the Diagnosis and Management of Patients With Suspected and Established Inflammatory Bowel Disease
Torsten Kucharzik, Mariangela Allocca, Joana Torres, et al.
Expert Review of Gastroenterology & Hepatology
|
January 15, 2016
Emerging therapeutic targets and strategies in Crohn's disease
Federica Furfaro, Gionata Fiorino, Mariangela Allocca, et al.
Journal of Gastroenterology
|
July 9, 2024
Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment-insights from Phase II and III trials
Sara Massironi, Federica Furfaro, Sarah Bencardino, et al.
Page
of 18